Davinthra Thillainathan
Stock Analyst at Goldman Sachs
(1.80)
# 3,405
Out of 4,978 analysts
37
Total ratings
43.5%
Success rate
0.5%
Average return
Main Sectors:
Stocks Rated by Davinthra Thillainathan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RHC Ramsay Health Care Limited | Upgraded: Buy | $54.10 | $54.98 | -1.60% | 5 | Aug 27, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Downgraded: Sell | $3.30 → $2.08 | $2.88 | -27.78% | 2 | Aug 6, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Upgraded: Hold | $2.10 → $2.15 | $2.33 | -7.73% | 2 | Jun 1, 2026 | |
| ASX: ANN Ansell Limited | Initiated Coverage: Hold | $31.80 | $41.96 | -24.21% | 1 | Apr 7, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | $52.97 → $54.58 | $44.39 | +22.96% | 5 | Feb 23, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | $49.30 → $53.20 | $32.13 | +65.58% | 9 | Feb 2, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $304.60 → $212.10 | $177.18 | +19.71% | 5 | Oct 29, 2025 | |
| ASX: NAN Nanosonics Limited | Initiated Coverage: Buy | $6.87 | $2.90 | +136.90% | 1 | Sep 25, 2025 | |
| ASX: HLS Healius Limited | Reiterated: Sell | $1.20 → $0.80 | $0.44 | n/a | 2 | Aug 12, 2025 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | n/a | $136.04 | n/a | 4 | Jun 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32.20 | $19.63 | n/a | 1 | Apr 3, 2025 |
Ramsay Health Care Limited
Aug 27, 2026
Upgraded: Buy
Price Target: $54.10
Current: $54.98
Upside: -1.60%
Australian Clinical Labs Limited
Aug 6, 2026
Downgraded: Sell
Price Target: $3.30 → $2.08
Current: $2.88
Upside: -27.78%
Integral Diagnostics Limited
Jun 1, 2026
Upgraded: Hold
Price Target: $2.10 → $2.15
Current: $2.33
Upside: -7.73%
Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $41.96
Upside: -24.21%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Reiterated: Buy
Price Target: $52.97 → $54.58
Current: $44.39
Upside: +22.96%
ResMed Inc.
Feb 2, 2026
Reiterated: Buy
Price Target: $49.30 → $53.20
Current: $32.13
Upside: +65.58%
CSL Limited
Oct 29, 2025
Reiterated: Buy
Price Target: $304.60 → $212.10
Current: $177.18
Upside: +19.71%
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $6.87
Current: $2.90
Upside: +136.90%
Healius Limited
Aug 12, 2025
Reiterated: Sell
Price Target: $1.20 → $0.80
Current: $0.44
Upside: n/a
Cochlear Limited
Jun 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $136.04
Upside: n/a
Apr 3, 2025
Initiated Coverage: Buy
Price Target: $32.20
Current: $19.63
Upside: n/a